Although adult murine B cells can be stimulated to proliferate by IgM receptor cross-linking, we and others have shown that these cells will undergo apoptosis In vitro In a dose-, time-and temperature-dependent manner with polyclonal but not monoclonal antl-lgM. To test the role of c-myc and cell cycle progression in B cell apoptosis, we examined normal, Sp6 antl-TNP Ig and E^-myc transgenlc splenocytes for receptor-mediated apoptosis In vitro. In normal mice, both spontaneous and antl-lgM-lnduced programmed cell death were specifically blocked by antisense oligodeoxynucleotides for the c-myc proto-oncogene, whereas nonsense myc ollgonucleotides and irrelevant oligonucleotides had only a minor effect. Similarly, TNP-dextran-lnduced apoptosis In Sp€ antl-TNP transgenlcs was inhibited by antisense c-myc. This effect was not due to the mitogenlc effects of unmethylated CpG-contalnlng sequences because ones lacking this motif, as well as methylated oligonucleotides containing this motif, prevented apoptosis, and mltogenic doses of llpopolysaccharlde failed to Inhibit antl-lgM-driven cell death. Importantly, antisense c-myc also prevented the antl-lgM-lnduced Increase In myc protein species. Moreover, spontaneous apoptosis In vitro was exaggerated In E^-myc transgenlc B cells. To examine the role of CD45 in anti-lgM-induced apoptosis, we treated spleen cells from CD45 knockout mice, which do not proliferate with anti-IgM, and found that B cells from these underwent apoptosis normally despite the lack of entry into S. These data suggest that anti-IgM driven apoptosis does not require CD45. Rather, apoptosis may be due to an overexpression of myc protein in the absence of signals which can drive B cells productively Into S, but the failure to proliferate normally Is insufficient for apoptosis to occur.
Introduction
Cross-linking membrane IgM on adult murine splenocytes normally induces an evanescent up-regulation of c-myc, exit from G o , and progress through G^ and into S, provided appropriate cytokines are present (1, 2) . In contrast, anti-IgM treatment of neonatal B cells does not induce proliferation and generally leads to unresponsiveness (3, 4) . In fact, using flow cytometry, we previously reported that a subset of neonatal B cells was deleted by anti-IgM treatment either in vivo or in vitro (5, 6) . Carsetti et al. (7) recently reported that TNP-dextran could induce apoptosis in a subset of adult B cells in Sp6 transgenic animals expressing rearranged receptors for the TNP hapten. Although early studies indicated that low-dose anti-IgM treatment of adult B cells leads to anergy (8, 9) , more recent data from Klaus' laboratory (10) indicate that extensive cross-linking of membrane IgM on adult B cells induces apoptotic cell death. The molecular inhibition of apoptosis is defined as a reduction of the number of <2/V nuclei to within 5% of background, spontaneous apoptosis or below d Data not shown and ref. 17. pathways leading to this induction of apoptosis in adult B cells are largely unknown. In contrast to normal splenocytes, murine B cell lymphomas have been used as a model for receptor-driven apoptosis for several years. In one model, we and others have shown that anti-IgM cross-linking of membrane IgM receptors leads to increased transcription of the early response genes, cell cycle arrest in G, and eventual apoptosis (11) (12) (13) (14) (15) (16) . A role for myc in the induction of apoptosis has been proposed from the observation that anti-IgM causes the evanescent rise and then the loss of myc in B cell lymphomas (14, 17) , and that overexpression of myc protein(s) at critical cell cycle barriers or in the absence of other progression signals leads to programmed cell death via apoptosis in other cell types (18, 19) Recently, one of us (17) reported that antisense oligodeoxynucleotides for c-myc protected against anti-IgMinduced apoptosis in vitro. Interestingly, in these cells, c-myc message and protein levels were stabilized, a result confirmed by Sonenshem and colleagues (personal communication, cf 20). These results imply that dysregulation of myc can lead to apoptosis
To explore the molecular pathways leading to apoptosis in normal B cells and to determine whether apoptosis occurred via a myc-dependent pathway involving signals required for cell cycle entry, we examined spleen cells from CD45 knockout mice, as well as anti-TNP transgenic, E^-myc transgenic or normal adult mice, for their proliferative and apoptotic responses to IgM receptor cross-linking. We discovered that the induction of apoptosis could be dissociated from stimulation of B cell growth since CD45 knockout mice failed to undergo anti-lgM-driven proliferation but still were induced to die. We also found that Ig receptor cross-linking induced significant apoptosis above background in both normal and TNP-specific transgenic mouse B cells in a dose-dependent manner. Furthermore, we report herein that antisense oligodeoxynucleotides against the c-myc proto-oncogene mRNA also prevented apoptosis (17) and that spontaneous apoptosis was much higher in E^-myc transgenic B cells, a result suggesting a role of myc in normal B cell apoptosis. We propose that appropriate cross-linking of B cell IgM receptors in adult B cells leads to apoptosis in the absence of co-stimulation to promote productive cell cycle progression. These results confirm that myc dysregulation in E^-myc transgenics can lead to pronounced B cell apoptosis and that extensive cross-linking of surface Ig receptors may drive B cells abortively in cycle and toward an apoptotic pathway via myc in adult splenocytes (16) . We further propose that the CD45 phosphatase is not required for this process, which occurs unchecked in neonatal B cells (6) .
Methods

Antibodies, mice and cell culture
Goat polyclonal anti-IgM (n chain specific) was purchased from Southern Biotechnology (Birmingham, AL) or Jackson ImmunoResearch (West Grove, PA). Purified rabbit anti-IgM also was made by immunization with a monoclonal IgM (|I,K) followed by affinity purification on an IgM, X (MOPC104E) column by standard methods (8); these gave similar results to the goat anti-IgM reagents. Monoclonal anti-n, b7.6, was purified on IgM columns as above; rat anti-mouse Fc receptor, 2.4G2, was grown as ascites and purified via Protein Gagarose; both monoclonals were obtained from ATCC (Rockville, MD).
Normal BALB/c, C57BL/6 or B6D2 F, mice were obtained from the Jackson Laboratory (Bar Harbor, ME); Sp6 anti-TNP transgenic mice (21) and their BALB/c or C57BL/6 controls were from the breeding facility at the Max-Planck Institut fur Immunbiologie (Freiburg, Germany); E^-myc transgenic mice were bred at the University of Cincinnati (22, 23) ; CD45 knockout mice were obtained courtesy of Dr Tak Mak, Amgen Institute, University of Toronto (24) . Except where noted, spleen cells from these mice were prepared by standard techniques (8) and cultured without further purification, to reduce background apoptosis caused by manipulation and complement. Unless otherwise noted, cells from individual mice were cultured separately.
Analysis of apoptosis by flow cytometry and propidium iodide staining
Unless specified, whole spleen cell populations were incubated at 5xiO 6 /ml as indicated below, washed and labeled with FITC-coupled 6B2 anti-B220 before fixation with 1 ml 70-100% absolute ethanol. These fixed cells were then placed at 4°C overnight, washed and resuspended in 1 ml PBS containing 10 ng/ml RNase (Sigma, St Louis, MO); cells were then incubated at 37°C for 30 min, after which propidium iodide (Sigma, 50 ng/ml) was added. The B220 + cells were then gated for propidium iodide analysis of DNA content (7) .
No other gating was done in initial experiments in order to measure all events (Freiburg), in subsequent studies, debris and doublets were gated out with similar results. To directly demonstrate apoptotic bodies, 10 (il of each cell suspension was placed on slides and apoptotic bodies visualized by fluorescence confocal microscopy and recorded for the presence or absence of fragmented nuclei (7, 16) . B cell apoptosis was confirmed using this method (R Carsetti and D. Scott, unpublished) . In some cases, small, resting B cells were purified by treatment with cytotoxic anti-T cell cocktail plus baby rabbit complement followed by Percoll gradient centrifugation.
Antisense oligodeoxynucleotides
Phosphorothioate (S) oligodeoxynucleotides for c-myc were initially designed against the translational start site in exon 2; a nonsense sequence was derived by randomizing the antisense sequence and used as a control oligo All oligodeoxynucleotides were purchased from Midland Certified Reagents (Midland, TX) or synthesized at the Max-Planck Institut fur Immunbiologie, Freiburg, or the Holland Lab over a 3 year period with similar results. The sequences used were: antisense c-myc, 5'-GAAGTTCACGTTGAGGGGCAT-3', nonsense c-myc, 5'-ATCTGGTGAGGGCAAGCTATG-3', which we previously used successfully with murine B cell lymphomas (17) . In addition, antisense c-fos (15), sense myc, sense and nonsense max were used as irrelevant controls, which were without effect (Table 1 and unpublished data). It is noteworthy that Kneg et al. (25) recently reported that oligonucleotides containing an unmethylated CpG motif preferably flanked by 3' pyrimidines and 5' purmes, were mitogenic for murine B cells. Therefore, these oligonucleotides and others which either contained or lacked the CpG motif were checked for both mitogenicity, activity in the apoptosis assay, as well as endotoxin contamination based on the Limulus assay. Although they were lipopolysaccharide (LPS)-negative, these oligonucleotides possessed variable mitogenicity for murine B cells; moreover, their mitogenic potency did not correlate with the prevention of apoptosis (see below). To address the effects of this motif, additional oligonucleotides were prepared as described in the Results section.
Immunoblotting for c-myc protein
Ten million splenic cells were treated for 3-6 h alone or with anti-IgM, in the presence or absence of antisense/control oligonucleotides Immunoblotting was essentially as described by Fischer et al. (17) . Briefly, after washing with ice cold PBS, cells were resuspended in 2xSDS lysing buffer, boiled, separated on 8% SDS-polyacrylamide gels, transferred to nitrocellulose, blocked and then incubated with rabbit antimouse myc (UBI, Lake Placid, NY) at 1 ng/ml for 2 h at room temperature. After washing, blots were probed with mouse anti-rabbit IgG (1 ^g/ml; Jackson ImmunoResearch) conjugated to alkaline phosphatase; NBT and BCIP were used for visualization of the bands. The blots were scanned using NIH Image and 1-D Gelscan (Scanolytics, Billerica, MA).
Results
Polyclonal anti-IgM induces apoptosis in adult normal B cells
Anti-lg treatment can lead to deletion of neonatal B cells (6) or a subset of adult lgM h ' 9h B cells via apoptosis in vivo or in vitro (7, 26) . During the course of our analysis of the requirements for the induction of apoptosis in the adult B cell pool by multivalent antigen, we noticed that a significantly increased portion of normal adult B cells became apoptotic upon extended treatment with anti-IgM. This effect was dose-, time-and temperature-dependent (27) . As reported by Ashman and colleagues (28, 29) and demonstrated in Fig. 1 , cultured B cells typically showed spontaneous apoptosis in 15-35% of the cells. Freshly isolated splenocytes contain virtually no apoptotic cells (data not shown and 27), presumably due to rapid uptake and removal by phagocytic cells in vivo. Treatment with anti-IgM (at concentrations of 10 ng/ ml or greater) increased the extent of apoptosis to 30-75% in most experiments, a phenomenon which was observed with whole spleen or purified B cells (Fig. 1A and B ) from normal BALB/c, C57BL/6, C3H/HeJ, B6D2 and with Sp6 transgenic B cells, albeit with consistent strain-dependent variations (data not shown). This process requires physiologic temperatures since it is not observed at 4°C either with and without anti-lg (data not shown). In general, comparable levels of apoptosis were induced in normal and Sp6 transgenic B cells by polyclonal anti-IgM but not by several monoclonal anti-IgM, such as b7.6( Fig. 1C) , or monoclonal anti-8 reagents (Scott and Carsetti, unpublished), a result that is consistent with extensive cross-linking being required for apoptosis, as reported earlier (10) . Both intact rabbit anti-IgM and F(ab') 2 fragments derived therefrom induced similar degrees of apoptosis; however, results varied with different batches of antibody rather than with the form and could be due to intact IgG contamination of F(ab') 2 fragments (unpublished). Therefore, to eliminate a role of Fc down-regulation in apoptosis, we treated normal spleen cells with goat anti-IgM plus 2.4G2 monoclonal anti-FcR The results in Fig. 1(D) suggest that apoptosis does not require Fc cross-linking to membrane IgM since anti-FcR did not block this process Importantly, there was no correlation with the ability or inability of these antibodies to induce B cell proliferation and apoptosis. Thus, receptor-mediated B cell apoptosis is T cell independent and occurs if sufficient cross-linking of membrane IgM occurs, regardless of whether the B cells are productively driven to enter the cell cycle.
Is CD45 required for the apoptotic signal via anti-IgM?
Mice in which the B220 (CD45) gene has been knocked out have relatively normal levels of B cells (24, 30) but fail to proliferate in response to anti-IgM, a defect which has been attributed in part to alterations in calcium influx (30) . To examine the role in apoptosis of CD45, we treated spleen cells from CD45 knockout mice with anti-IgM under the conditions shown above to be effective for the induction of apoptosis. Although B cells from these mice failed to proliferate (Fig. 2, see legend) , they still underwent apoptosis normally. These data suggest that anti-lgM-driven apoptosis does not require CD45. It should be noted that while anti-IgM failed to induce B cell proliferation in CD45 knockout mice, it did lead to a loss of the p27 kinase inhibitor (S. Ezhevsky and D. W. Scott, in preparation). Thus, the induction of apoptosis is not CD45 dependent nor is it a consequence of the failure to modulate p27 and exit from G o into the cell cycle, a conclusion which can also be drawn from the induction of apoptosis with goat anti-IgM in the presence or absence of Fc receptor cross-linking
Effect of antisense oligodeoxynucleotides against c-myc on anti-IgM induced and spontaneous apoptosis
As shown above, the extent of apoptosis is increased in the presence of high concentrations of cross-linking antibodies to surface IgM. Anti-IgM has been shown to induce the evanescent transcription of c-myc message in resting B cells, as in lymphomas (14, 17, 31) . Since c-myc has been implicated in driving many cell types, including fibroblasts, and B and T cells, into apoptosis (18, 19) , we attempted to modulate myc synthesis during apoptosis using antisense oligonucleotides This approach has been used successfully by ourselves and others recently (17, 19) . Normal BALB/c or Sp6 transgenic splenocytes were pretreated with antisense ohgodeoxynucleotides directed against the first translational start site in c-myc, and then anti-IgM ( Fig. 3A and B) or TNP-dextran (Fig. 4) were added. The results reveal several important points. Firstly, antisense but not nonsense c-myc significantly reduced spontaneous apoptosis (Fig. 3A) and prevented anti-lgM-induced apoptosis in a dose-dependent manner (Fig. 3B) . Moreover, antisense c-myc also blocked TNP-dextran-induced apoptosis in antigen-specific Sp6 transgenic B cells (Fig. 4) This block was dose dependent and specific for myc since nonsense c-myc oligonucleotides and antisense c-fos and sense max were without effect (data not shown; see Table 1 ).
Note that some of these oligonucleotides contain the CpG motif that can be mitogenic for murine B cells (25) . To address the effects of this motif, additional oligonucleotides were prepared as follows. For example, oligonucleotides designed against a downstream sequence, lacking the motif, also blocked apoptosis (Fig. 3C) . Additional oligonucleotides in which a single base change was introduced in the motif were found to be less effective than the original in blocking apoptosis, as would be expected since their ability to hybridize would be reduced (unpublished). Finally, we made antisense c-myc oligonucleotides with methylated cytosine, as found in mammalian DNA, in the motif or treated the original ones with methylase. These methylated oligonucleotides were as effective as nonmethylated ones (Fig. 3C ), but were nonetheless mitogenic (data not shown). Therefore, there was no direct correlation between mitogemcity and prevention of apoptosis in this model (Table 1 and unpublished data). Nonetheless, we Fig. 1(A) . The percent apoptosis is indicated above the <2/V peak. In parallel cultures, anti-IgM stimulated B cell proliferation at 48 h was as follows (in c.p.m.): normal C57BI/ 6 background, 4749; 1 ng/ml anti-n, 13,162; 3 ng/ml anti-n, 28,183, 10 ng/ml anti-n, 25,435, 10 ng/ml LPS, 32,960; CD45 KO background, 3989; 1 |ig/ml anti-n, 2643; 3 ng/ml anti-n, 3268; 10 ng/ml anti-n, 5913; 10 ng/ml LPS, 31,004. One of three similar experiments decided next to examine whether a known B cell mitogen, LPS, could block apoptosis.
Effect of LPS on receptor-mediated apoptosis
Polyclonal B cell mitogens, like LPS, are known to interfere with the induction of tolerance in normal B cells in vivo (32) and apoptosis in B lymphoma cells in vitro (33, 34) . To test whether LPS blocked the induction of apoptosis in splenic B cells, we treated cells with anti-IgM plus LPS and performed propidium iodide analysis for apoptosis 24-30 h later. The results in Fig. 5 indicate that LPS does not interfere significantly with apoptosis induced by anti-IgM in normal splenic B cells despite its potent mitogeneicity for murine B cells. Further analysis with normal or Sp6 transgenic B cells treated with anti-IgM or TNP-dextran respectively revealed that LPS did not block B cell activation-induced apoptosis whether added simultaneously or up to 4-6 h prior to receptor ligation or simultaneously, although it did reduce background apoptosis (R. Carsetti ef a/., unpublished). This argues against the possibility that the effects of antisense oligonucleotides on apoptosis, described above, are due to the mitogenicity of oligonucleotides containing an unmethylated CpG motif (25) .
Effect of antisense c-myc oligodeoxynucleotides on myc protein levels
To further validate the use of antisense oligonucleotides, as well as to determine at which level anti-IgM was acting and to further implicate a role for myc in apoptosis, B cells were examined for the presence of c-myc protein by Western blotting as follows Normal splenic B cells were cultured in medium or with anti-IgM for 3 h in the presence or absence of antisense or nonsense c-myc oligonucleotides, the cells harvested, lysates separated by PAGE and blotted with antic-myc, as described earlier (17) The results (Fig. 6) indicate that the anti-lgM-induced increase in c-myc was prevented in the presence of antisense, but not nonsense oligonucleotides to c-myc. That is, anti-IgM stimulated a 4.3-fold increase in c-myc protein within 3 h (compared with medium alone), whereas only a 2.5-fold change was induced by anti-IgM in the presence of antisense c-myc; anti-IgM stimulated a 4-fold increase in the presence of the nonsense oligonucleotide, an important control result. Therefore, these data in toto suggest that myc protein plays a role in both spontaneous and IgM receptor induced normal B cell apoptosis. This was further examined in E u -myc transgenic mice.
Spontaneous apoptosis is increased in E^-myc transgenic mice
Overexpression of c-myc in the B cell compartment can lead to the development of B cell lymphomas within months Despite being neoplastic, many of these tumors display high rates of spontaneous apoptosis, presumably because of myc dysregulation and ineffective clearance mechanisms are missing in situ in the tumors (22, 35) . To examine whether overexpression of c-myc in pre-neoplastic mice affected the rates of spontaneous and induced apoptosis, we cultured spleen cells from individual E^-myc and control, non-transgenic C57BL/6 littermates in medium or with anti-IgM as above. The results in Fig. 7 indicate a high rate of spontaneous apoptosis in -60% of E^-myc transgenic B cells, but that anti-IgM did not significantly increase this above background, in contrast to normal controls. Interestingly, antisense against c-myc also reduced the amount of spontaneous apoptosis more than it did anti-lgM-induced apoptosis (data not shown). These data imply that dysregulation of myc may predispose these transgenic B cells to apoptosis.
Discussion
Cross-linking of membrane Ig receptors is important not only as the first step in B cell activation for cell cycle entry, but also for the initiation of immunologic tolerance. Differentiation between these opposing sequelae is dependent on the age of the target B cell and/or the presence of second signals, such as those derived from T cell contact and cytokines. For example, incubation of neonatal murine B cells with anti-IgM as a surrogate for antigen has been shown to result in significant B cell death via apoptosis (3, 6) . We and others have demonstrated that adult murine spleen cells also undergo dose-, time-and temperature-dependent apoptosis in vitro with anti-IgM treatment (7, 10, 27) . The fact that high concentrations of polyclonal (but not monoclonal) anti-IgM are necessary for this process suggests that the induction of apoptosis requires extensive cross-linking of membrane IgM, as described by Parry et al. (10) . Herein, we show that this process is blocked by antisense oligodeoxynucleotides for the c-myc proto-oncogene, which specifically block the antiIgM-driven increase in myc protein expression. Coupled with high level of spontaneous apoptosis in E n -myc transgenic B cells, these results that suggest that myc protein may play a role in the apoptotic process in B cell tolerance. Furthermore, we show that apoptosis occurs normally in CD45 knockout mice that are not induced to proliferate by this stimulus, a result that implies that this process is independent of productive entry in to the cell cycle, which requires CD45 function. This also suggests that induction of myc synthesis by IgM cross-linking does not require the CD45 phosphatase, a result which is supported by our recent data (not shown). However, the fact that anti-IgM induced significant apoptosis in the presence of anti-FcR suggests that at least a subset of B cells undergoes apoptosis concurrent with apparently normal entry into S, as also shown by Chen (36) . Nonetheless, our results are consistent with abortive entry into cycle preferentially driving B cells toward apoptosis, a logical failsafe
It is important to note that many of the oligonucleotides employed contain an unmethylated CpG motif, believed be mitogenic for murine B cells (25) Therefore, we examined antisense c-myc, as well as control nonsense and other antisense constructs for mitogenicity, but found that there was no correlation between mitogenicity and prevention of apoptosis by antisense oligonucleotides. In addition, while LPS reduced spontaneous apoptosis, it had no effect on antiIgM or TNP-dextran (data not shown) induced apoptosis. Therefore, mitogenicity of the oligonucleotides cannot explain our results, which suggests that myc may regulate both spontaneous and IgM-receptor induced normal B cell apoptosis.
Our data further demonstrate that adult B cells can be deleted via apoptosis if sufficient cross-linking of membrane IgM occurs (10) . It is noteworthy that anti-lg cross-linking can cause an evanescent increase in c-myc transcription (31; B. Maddox and D. W. Scott, unpublished) and translation. Interestingly, co-culture with IL-4, which promotes cell cycle progression and prevents apoptosis (10,28; A. Keegan et al., unpublished data) does not change the kinetics or the level of c-myc message detectable in Northerns (31) . How can we explain these results in terms of the role of myc in apoptosis? We suggest that myc protein (species) functions to drive both the spontaneous and anti-lgM-induced apoptotic pathways in part via cell cycle entry in the absence of progression signals for continued B cell proliferation such as those provided by IL-4 and CD40-gp39 interaction. Therefore, it is interesting to note that anti-CD40 (10) or soluble CD40L (27) both can prevent anti-lgM-driven apoptosis. Whether these reagents fail to modulate myc synthesis or up-regulate/ activate the kinase complexes necessary for cell cycle progression is under study.
The fact that E^-myc transgenic mice show increased spontaneous apoptosis is consistent with previous observations showing a higher rate of cell death in spleen cells explanted from E^-myc transgenic mice (35) . These studies demonstrate that this is due to apoptosis and, moreover, that Fig. 3 , except that 3-10 nM oligodeoxynucleotides was added 3 h before a 27 h culture with medium (Control, A) or with anti-IgM at 10 jig/ml (A). (A) The percent apoptotic cells in the control cultures was 10%, in the presence of 3 and 10 |iM nonsense myc, 9 and 8% respectively; in the presence of 3 and 10 |iM antisense myc, this was reduced to 3 and 2% respectively. (B) The percent apoptotic cells with 10 ng/ml anti-IgM was 24%; in the presence of 3 and 10 nM nonsense myc, 18 and 23% respectively; in the presence of 3 and 10 |i(v) antisense myc, this was reduced to 12 and 9% respectively. One of four similar experiments. (C) Effect on additional oligonucleotides on anti-|i-mduced B cell apoptosis Protocol as above except that antisense c-myc lacking the CpG motif was identified downstream of the start site (after a 12 base interval) and was used at 1 nM. The sequence employed was 5'-ATAGTTCCTGTTGGTGAAGTT. Data are presented as percent apoptosis In addition, oligonucleotides identical to the original (designed at the translational start site) were synthesized with methylated C in the motif. In both cases, the prevention of apoptosis was similar to the original oligonucleotides and nonsense oligonucleotides derived from the same bases were without effect on apoptosis (data not shown) Fig. 3 , except that TNP-dextran was used at 100 jig/ml to induce apoptosis. Both spontaneous apoptosis (control; left panels) and that induced by specific TNP-dextran (right panels) were unaffected by nonsense oligonucleotides, but were both blocked by antisense to c-myc. The percent apoptotic cells in the control cultures v/as 19%; in the presence of nonsense myc, 15%; in the presence of antisense myc, this was reduced to 4% (left panels). The percent apoptotic cells with TNP-dextran was 31%, in the presence of nonsense myc, 26%; in the presence of antisense myc, this was reduced to 3% (right panels). One of two similar experiments 
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Time of addition of 10 ng/ml LPS to 30 ng/ml anti-^i(hrs) Densitometric Units Fig. 6 . Effect of antisense c-myc on c-myc protein levels. Normal splenic B cells were cultured in medium or with anti-IgM ± antisense or nonsense c-myc ohgonucleotides and the lysates immunoblotted as described (17) . At 3 h, myc protein synthesis is apparent with antiIgM alone or with nonsense c-myc, but myc species are decreased in cells treated with anti-IgM plus antisense c-myc. Densitometry scans of this blot are displayed in the lower panel; histograms were generated in NIH Image and the data generated for the major myc bands using the 1-D Gelscan program c-myc plays a major role in this process. Importantly, our studies also confirm that myc levels regulate the induction of apoptosis, as previously reported by Evan et al. (18) and Shi and colleagues (19) . It is noteworthy that c-myc can either induce (18, 19) or prevent apoptosis (17) , presumably by (38) , at least at the initiation of an immune response. It will be interesting to determine whether these results reflect a balance between the dual roles of myc and the possible relationship of its synthesis with the CD407 gp39 family of receptors/ligands, as well as transcription of anti-apoptotic genes like the bcl family, will be an important development in our understanding of apoptosis.
